BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu Y, Chen Y, Ma J, Yu X, Yu G, Li Z. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma. Tumour Biol 2016;37:4159-67. [PMID: 26490986 DOI: 10.1007/s13277-015-4206-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Wu J, Liu Z, Gao J, Li S, Gao D. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/1398268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Klingler A, Regensburger D, Tenkerian C, Britzen-Laurent N, Hartmann A, Stürzl M, Naschberger E. Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues. PLoS One 2020;15:e0233422. [PMID: 32437418 DOI: 10.1371/journal.pone.0233422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Liu X, Zhao J, Luan X, Li S, Zhai J, Liu J, Du Y. SPARCL1 impedes trophoblast migration and invasion by down-regulating ERK phosphorylation and AP-1 production and altering EMT-related molecule expression. Placenta 2020;89:33-41. [PMID: 31675488 DOI: 10.1016/j.placenta.2019.10.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wang J, Yu XF, OUYang N, Luo QL, Zhao SY, Guan XF, Chen T, Li JX. Multi-platform analysis of methylation-regulated genes in human lung adenocarcinoma. J Toxicol Environ Health A 2019;82:37-45. [PMID: 30626254 DOI: 10.1080/15287394.2018.1551645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Shen C, Yin Y, Chen H, Wang R, Yin X, Cai Z, Zhang B, Chen Z, Zhou Z. Secreted protein acidic and rich in cysteine-like 1 suppresses metastasis in gastric stromal tumors. BMC Gastroenterol 2018;18:105. [PMID: 29973149 DOI: 10.1186/s12876-018-0833-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Li T, Liu X, Yang A, Fu W, Yin F, Zeng X. Associations of tumor suppressor SPARCL1 with cancer progression and prognosis. Oncol Lett 2017;14:2603-10. [PMID: 28927026 DOI: 10.3892/ol.2017.6546] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]